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Abstract
Background: One of the challenges in the analysis of microarray data is to integrate and compare
the selected (e.g., differential) gene lists from multiple experiments for common or unique
underlying biological themes. A common way to approach this problem is to extract common
genes from these gene lists and then subject these genes to enrichment analysis to reveal the
underlying biology. However, the capacity of this approach is largely restricted by the limited
number of common genes shared by datasets from multiple experiments, which could be caused
by the complexity of the biological system itself.
Results: We now introduce a new Pathway Pattern Extraction Pipeline (PPEP), which extends the
existing WPS application by providing a new pathway-level comparative analysis scheme. To
facilitate comparing and correlating results from different studies and sources, PPEP contains new
interfaces that allow evaluation of the pathway-level enrichment patterns across multiple gene lists.
As an exploratory tool, this analysis pipeline may help reveal the underlying biological themes at
both the pathway and gene levels. The analysis scheme provided by PPEP begins with multiple gene
lists, which may be derived from different studies in terms of the biological contexts, applied
technologies, or methodologies. These lists are then subjected to pathway-level comparative
analysis for extraction of pathway-level patterns. This analysis pipeline helps to explore the
commonality or uniqueness of these lists at the level of pathways or biological processes from
different but relevant biological systems using a combination of statistical enrichment
measurements, pathway-level pattern extraction, and graphical display of the relationships of genes
and their associated pathways as Gene-Term Association Networks (GTANs) within the WPS
platform. As a proof of concept, we have used the new method to analyze many datasets from our
collaborators as well as some public microarray datasets.
Conclusion: This tool provides a new pathway-level analysis scheme for integrative and
comparative analysis of data derived from different but relevant systems. The tool is freely available
as a Pathway Pattern Extraction Pipeline implemented in our existing software package WPS, which
can be obtained at http://www.abcc.ncifcrf.gov/wps/wps_index.php
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Microarray and other high throughput (HTP) technolo-
gies have exponentially increased in popularity in recent
years and consequently have generated tremendous
amounts of data. This data provides great opportunities
for systems-level understanding of the underlying biolog-
ical themes of complex experiments. As a result, a wide
range of software tools that process and analyze the data
using different approaches and algorithms have been
developed including clustering methods (e.g., hierarchical
[1]; K-means [2], SOM [3]) methods, pattern extraction
method [4], identifying differential gene lists from two or
more classes contrasts (e.g., Significance Analysis of
Microarray [5], LPE [6], and analysis of variance (ANOVA)
related methods [7,8]). In order to place these patterned
or differential genes into their biological contexts, they
can be mapped into pathways or networks for further
analysis of biological associations and relationships
among them as well as other documented relevant genes
curated from the literature [4,9-11]. Alternatively, func-
tional group or gene set overrepresentation analysis
(ORA) methods [12-14] or gene set-based enrichment
analysis (e.g., GSEA [15,16]) can be used to identify the
significantly affected pathways or gene sets that are
enriched or over-represented within a list of patterned or
differential genes.
The enormous increase in availability of data from studies
using similar biological systems, independent samplings,
and/or technical platforms (e.g., microarray, proteomics)
allows an integrative and comparative analysis to be per-
formed. This provides for a deeper understanding of the
underlying biology and consolidation of initial observa-
tions made from individual studies. Furthermore, the sys-
tems-oriented approach allows for additional insights
from combined datasets. For example, diseases such as
prostate cancer have been studied by many different
groups. These data from different platforms and inde-
pendent samplings provide the opportunity not only to
assess the consensus of these studies and the variation lev-
els of the patient population, but also to perform integra-
tive analysis for signatures at both gene and pathway level.
A conventional way to integrate and compare multiple
experiments derived from independent research groups or
even different technologies for common or unique under-
lying biological themes is to derive common genes
amongst them before subjecting them to enrichment
analysis to reveal the underlying biology. However, such
an approach often encounters limitations caused by the
diversity of technologies and the complexity of the biolog-
ical system itself.
Many of the available software tools primarily retrieve
expression patterns at the individual gene level and gener-
ate a list of genes that are differentially expressed or have
certain expression patterns across samples. Even the soft-
ware tools that employ ORA or GSEA methods [14-16],
usually consider only one or very limited number of gene
lists at a time. Although a great deal of attention was
placed on gene-level expression patterns initially, there is
an urgent need for capturing the pathway-level patterns
that may represent the common or unique biological
themes, which are embedded in multiple genes lists or
multiple datasets from different, but related studies.
It has become more and more evident that gene level sig-
natures or classifiers that can consistently characterize dif-
ferent tumor types are relatively hard to validate across
different studies due to the complexity of the underlying
biology (e.g., large genetic variations within the pheno-
typical population), experimental variation, and even the
choice of data processing (e.g., normalization, transfor-
mation) and analysis methods/algorithms. This observa-
tion likely results from the fact that many complex
diseases including cancers, heart disease and hypertension
have been shown to be caused by mutations in multiple
genes in the same or related pathways [17-20]. While bio-
logically relevant genes may consistently behave in corre-
lation with an associated phenotype across a population,
it is more likely that common pathways can be impacted
through distinct gene events that are not reflected at the
individual gene level. This seems particularly relevant
considering the stochastic nature of many epigenetic
events that lead to disease states. For example, evidence
derived from the studies on multiple prostate datasets of
different research groups has shown that many pathway/
gene set enrichment analysis or group testing methods
identified the same or related pathways/gene sets that
were either experimentally validated or believed to be
more likely involved in the pathogenesis of prostate can-
cer. Furthermore, these pathways/gene sets appear to be
more consistent and reproducible than simple gene signa-
tures between these datasets [21]. These, and similar
observations have fueled efforts to evolve from gene-level
signatures into pathway-level signatures. Similarly, eleva-
tion of gene-based classification methods into pathway-
based classification methods is now being actively pur-
sued in the field. The gene-by-gene approach or gene-level
paradigm failed to put single genes in an overall func-
tional context, and consequently ignored other relevant
genes that were known to have biological relevance or
showed similar expression profiles or correlation with the
phenotypes under study. Now that independent studies of
the same or similar subjects produced gene lists with very
low levels of overlap [21], it makes more sense to compare
these gene lists at the pathway-level for common and
unique biological significance.Page 2 of 17
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BMC Bioinformatics 2009, 10:200 http://www.biomedcentral.com/1471-2105/10/200Using this rationale as our motivation, we developed a
high-throughput Pathway Pattern Extraction Pipeline
(PPEP) within the existing pathway analysis tool WPS [4],
to specifically address the need for pathway-level compar-
ative analysis using pathway-level enrichment patterns.
The method can explore the biological commonality or
uniqueness at the level of a pathway or biological process
from different but relevant biological systems. With the
help of PPEP, we can intuitively visualize the patterns of
pathway-enrichment across the multiple gene lists or
datasets The method also reveals the relationships and
data behavior of the involved genes from the gene lists or
datasets that are associated with these pathways.
As a proof of concept of this exploratory tool, we have
used PPEP to analyze both public microarray datasets and
datasets from our collaborators. In summary, we found
that this new analysis pipeline dramatically enhanced the
ability of research investigators to uncover the underlying
biological themes that are shared or unique among differ-
ent but related systems represented by these genes lists or
datasets through pathway-level comparative analysis.
Implementation
Pathway pattern extraction pipeline dissects pathway-
level enrichment patterns for biological themes
The first version of WholePathwayScope or WPS provides
a platform for pattern extraction at the gene-level and also
allows generation of gene-term association networks
(GTANs) [4]. In this newly developed high-throughput
pathway pattern extraction pipeline (PPEP), we extended
that capacity into a pathway-level pattern extraction
method that retrieves the patterned pathways based on
enrichment levels of pathways across gene lists or data-
sets. From the patterned pathways, the associated genes
can be retrieved and displayed in the context of GTANs
[4]. The objective of such a method is to combine path-
way-level enrichment analysis, heatmap/clustering analy-
sis, and pattern extraction to look for pathway-level
enrichment patterns as underlying biological themes.
PPEP is implemented within the existing WPS software
platform and runs in the WPS environment. It utilizes an
enhanced WPS internal database with more species cover-
age (now including yeast, and malaria) and more func-
tional categories including GSEA gene sets, predicted
transcription factor target genes, and miRNA target genes
for human and mouse. The goal of PPEP is to perform
pathway-level comparative analysis of underlying biology
represented by multiple lists of signature genes, differen-
tial genes, or patterned genes derived from different stud-
ies, different groups, and/or even different technologies
and platforms. In our current release of WPS, PPEP works
side by side with our newly developed pathway-ranking
method-SLEPR [22] forming the main pathway-level anal-
ysis core utilities in WPS. Although our current version of
WPS is a Window-specific application, we are currently
planning to port this application to Java so that the oper-
ating system restriction will be removed.
As illustrated in Figure 1, PPEP consists of several func-
tional interfaces that allow a designated analysis proce-
dure to be executed in a step-by-step fashion. The modular
design through multiple interfaces allows the user to
assess results at each stage and then proceed as desired.
The generic step-by-step procedure for PPEP is described
as follows (Figure 1). First, multiple gene lists from differ-
ent sources are subjected to batch computation for enrich-
ment analysis for selected functional categories (Figure 2).
The enrichment analysis is performed using Fisher's exact
test, as described previously [4]. The result for each list is
written into an individual file. Next, the p-values of each
list for each term in these result files can be transformed
and merged together as a matrix of enrichment scores
(ESs) in a single Stanford format file [4], in which each
row is a term and each column is a gene list. Alternatively,
FDR and ListHits can be merged together in a similar way.
For step 3, the matrix of ESs can be subjected to clustering
analysis using many existing common clustering analysis
tools [23,24], PTM-based pattern extraction using TM4
from TIGR [23], or pathway pattern extraction within
PPEP (Figure 3 and 4). Then at step 4, the associated genes
can be retrieved from the patterned pathways (enrich-
ment-level based) (Figure 5). Finally, the retrieved genes
can be displayed in the context of GTANs, as described
previously [4] (Figure 6). The more detailed description
on the features and implementation of PPEP is included
into the Additional file 1 (Additional file 2, 3, and 4).
Data analysis using PPEP
The PPEP in WPS provides an opportunity to study the
underlying common or unique biological themes among
multiple gene lists derived from related but different sys-
tems or class comparisons. It can also be used to assess dif-
ferent datasets with the same or even different microarray
platforms or HTP datasets using other technologies that
measure different aspects of the biological systems. For
example, one could ask what can be found in common
between different studies of the same disease, since it has
been found in many cases that only a few common genes
are found for similar studies or for the same study but
with different analysis methods [21,25]. However, the lev-
els of consistency could be higher and more obvious
when evaluated at the pathway level. The result section of
this manuscript illustrates case studies with the PPEP
using real data examples to describe some analysis
schemes to seek common or unique biological themes
embedded in different studies.Page 3 of 17
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Schematic work flow of Pathway pattern extraction Pipeline (PPEP) in WPSFigure 1
Schematic work flow of Pathway pattern extraction Pipeline (PPEP) in WPS. The input of the analysis pipeline can 
be a set of gene lists derived from the same or even different study in terms of biological contexts, applied technologies and 
methodologies. Examples of the lists are differential gene lists from class contrasts obtained from microarray data analysis, pro-
teomic profiling, or genome-wide post-transcriptional modification scan. Then the first step is to batch compute the Fisher's 
exact test to evaluate the enrichment levels for each gene lists for annotated terms or pathways in WPS database (e.g., GOBP, 
Biocarta pathway). The Fisher's exact test for enrichment levels was described previously [4]. Step 2 is to collect the batch 
computation results and merging them into an enrichment score (ES) matrix. Then at step 3, the ES matrix can be subjected to 
pattern analysis using different methods under user's choice: clustering analysis, Pavlidis template matching, and pathway pat-
tern extraction. Clustering analysis and Pavlidis template matching can be done with external tools such as TM4 package from 
TIGR. The pathway pattern extraction is a newly designed feature in PPEP specifically for pattern extraction using ES score 
matrix. Then the next step or step 4, obtained terms or pathways after pattern analysis, usually as in a matrix or as a list, can 
be used to retrieve the associated genes using the interface of the analysis pipeline in WPS. Then at the final step, the data and 
association relation of the terms and genes can be viewed under GTAN display in WPS using WPS visualization capacity.
BMC Bioinformatics 2009, 10:200 http://www.biomedcentral.com/1471-2105/10/200Results
The major features and functionalities of the newly devel-
oped pathway pattern extraction pipeline (PPEP) in WPS
are illustrated using example data in the following sec-
tion. Although only microarray data is utilized here as
examples, any source of HTP data would be equally suita-
ble for the analysis with PPEP. More examples are also
provided as supplementary files.
Seeking common biological themes from different studies 
on the same subjects
One of the major advantages of PPEP is the ability to com-
pare the biological themes for multiple gene lists derived
from different studies at the pathway-level. To provide
examples of such an analysis scheme, we chose to use the
prostate cancer datasets derived from different research
groups and collected in the Oncomine database [26]. This
allows different studies on the same subjects to be com-
pared at both the gene and pathway levels. The reason we
chose prostate cancer is that this type of cancer has been
The interface of the PPEP for batch computation of Fisher's exact test of multiple gene lists and merging the result files for matr x of enrichment scoresFigure 2
The interface of the PPEP for batch computation of Fisher's exact test of multiple gene lists and merging the 
result files for matrix of enrichment scores. From each species-specific database, multiple functional categories can be 
selected for batch computation. Users have options merging p-values for enrichment scores, merging ListHits (how many 
genes from the lists hit the term), or merging -log10 transformed FDR values into a matrix. As default, Fisher's exact test p-val-
ues can be floored by criteria of p > 0.05 and ListHits <= 1 to make the corresponding enrichment scores as 0. However, users 
have options to either not floor the enrichment scores, or set up their own customized way to do the flooring. Other options 
are also provided: e.g., computing FDRs or not, or number of iterations for FDR computations.Page 5 of 17
(page number not for citation purposes)
BMC Bioinformatics 2009, 10:200 http://www.biomedcentral.com/1471-2105/10/200
Page 6 of 17
(page number not for citation purposes)
The interface for pathway pattern extraction of the PPEPFigure 3
The interface for pathway pattern extraction of the PPEP. User can browse to the data sources (e.g., a matrix of 
enrichment scores) in multiple file formats (text file, Microsoft Excel file and Access file), select Inclusion samples and Exclusion 
samples from sample list, set criteria for both Inclusion and Exclusion samples. There are also Extract Options for both Inclu-
sion and Exclusion samples so that a term with a portion of samples meets the criteria can be selected.
BMC Bioinformatics 2009, 10:200 http://www.biomedcentral.com/1471-2105/10/200well studied and there are many microarray datasets avail-
able on different platforms and from different research
groups. Our analysis goal is to compare the differential
genes derived from the different studies and to seek the
common biological themes as the consensus (e.g., path-
ways, GO terms, gene sets) that are embedded in these dif-
ferential gene lists.
From the Oncomine database, we downloaded a total of
6 microarray datasets that all specifically studied prostate
cancer [27-32] but with different microarray platforms
(e.g., Affymetrix, cDNA array, customized array etc.). The
Oncomine database [26] has done gene-level analysis on
each of these datasets and reported the differential gene
lists (at Q-value < 0.05) between prostate tumor and nor-
mal or benign tissues. We can immediately subject these
lists to analysis with PPEP. Since the same type of analysis
was applied to all of the datasets in the Oncomine data-
base, it is reasonable to assume that the statistical criteria
to generate the differential genes are consistent for all of
the datasets such that the derived differential gene lists can
be compared at pathway-level directly.
Conventionally, to identify the common elements
between datasets from different studies, the shared differ-
ential genes can be obtained, from which the biological
themes can be deduced using enrichment analysis meth-
ods [12,13]. It has also been reported that analysis at the
pathway level can improve the comparability of different
datasets [21]. Our PPEP method is intended to improve
the comparability of different datasets by simply extract-
ing pathway enrichment patterns.
To compare the conventional gene-level analysis method
with our pathway-level pattern extraction method imple-
mented in the PPEP, we first used WPS gene pattern
extraction feature to retrieve 52 genes, which are differen-
tially expressed between prostate tumor and normal tis-
An example of pathway pattern extraction results in a heatmapFigure 4
An example of pathway pattern extraction results in a heatmap. The data of patterned GO biological process terms 
for GNF dataset [43] was obtained with pathway pattern extraction, whose extraction template was set as shown in Figure 3: 
look for patterned terms that are enriched in at least 4 of 5 Inclusion samples (testis-related tissues: testis germ cells, testis 
interstitial, testis leydig cells, testis seminiferous tubule, testis), but not enriched in at least 72 of 74 Exclusion samples (the rest 
of tissues in GNF dataset).Page 7 of 17
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The interface of the PPEP for retrieval of associated genes with selected terms from pattern extraction results or other resourcesFigure 5
The interface of the PPEP for retrieval of associated genes with selected terms from pattern extraction results 
or other resources. Users first need to select the functional category for the intended terms (e.g., GO Biological Processes). 
Then the data source (i.e. a Stanford format file with the matrix of terms [4]) can be selected, from which intended terms can 
be selected. The gene list files that are originally used for batch computation of enrichment results can be selected into the 
<Selected Gene List Text Files> table. The retrieved gene-term relations are presented in a binary format (gene-term pairs), 
which can be either displayed in the table at the bottom of the interface, or saved as a file for future use. The retrieved pair-
wise gene-term relations displayed in the table can be immediately used to create a GTAN (gene-term association network: 
[4]) and visualize the data of the interested gene lists on the context of GTANs.
BMC Bioinformatics 2009, 10:200 http://www.biomedcentral.com/1471-2105/10/200sues and are commonly shared among all of the 6 datasets
(see Additional file 5). Then we subjected the list of these
52 genes (we called it 52-gene common gene list below)
to enrichment analysis in WPS from both GO (Gene
Ontology) Biological Processes (GOBP) and GSEA anno-
tation. Conventionally, the enriched terms from the 52-
gene common gene list would be treated as the common
biological themes among the 6 independent datasets. To
compare results with the conventional method, we
directly used our PPEP to do pathway pattern extraction
using the differential gene lists from all of the 6 datasets
for GOBP and GSEA annotations. For GSEA annotations,
our pathway pattern extraction method obtained 331
terms that are significantly enriched (P < 0.05 in each
dataset) consistently in differential gene lists of all 6 data-
sets (see Additional file 6). When the 52-gene common
gene list was used in the conventional enrichment analy-
sis for GSEA annotations, only 125 terms are significantly
enriched (see Additional file 7). Furthermore, among the
commonly enriched 331 terms that we obtained by path-
way pattern extraction, there are 33 terms directly
involved in cancer-related processes, which are shown in
the heatmap (see Additional file 8). Among these 33 can-
cer-related terms, only 7 are significantly enriched in the
52-gene common gene list (see Additional file 9). Simi-
larly, there are only 22 GO terms that are significantly
enriched in the 52-gene common gene list, while there are
44 GOBP terms derived from pathway pattern extraction
that are enriched consistently in the differential gene lists
(see Additional file 10 and 11). After taking a close look at
these GOBP terms, although there were many apoptosis-
related GOBP terms repeatly appearing in the patterned
term lists obtained from the PPEP (see Additional file 12),
there were no apoptosis or cell death related terms
enriched in the 52-gene common gene list (see Additional
file 11). Perturbation of apoptosis-related processes is
An example of GTAN view of the retrieved associated genes with the patterned terms derived from pathway pattern extrac-tionFigure 6
An example of GTAN view of the retrieved associated genes with the patterned terms derived from pathway 
pattern extraction. The associated genes of some selected GO biological process terms extracted from GNF dataset by 
pathway pattern extraction (Figure 4) was retrieved with the gene retrieval interface shown in Figure 5. The red color for 
genes shows that these genes are in the original gene lists of corresponding samples of testis-related tissues. The red color for 
pathways shows that there are more than 10% of associated genes for the corresponding terms, which are in the original gene 
lists of corresponding samples of testis-related tissues.Page 9 of 17
(page number not for citation purposes)
BMC Bioinformatics 2009, 10:200 http://www.biomedcentral.com/1471-2105/10/200well known to play critical role in carcinogenesis. These
observations suggested that our pathway pattern extrac-
tion method provided by the PPEP was able to uncover
many of the significant terms, which were missed by the
conventional gene-level based enrichment approach. The
pathway pattern extraction method may be much more
powerful than conventional gene-level based approach at
revealing the embedded biological themes. Importantly,
by identifying additional terms, the PPEP method pro-
vides the researcher with more information to consider
with their own biological domain expertise.
In order to evaluate how useful pathway pattern extrac-
tion would be from a generic perspective, we also used
PPEP to look for higher level enrichment patterns for tran-
scription factor targets, miRNAs targets and KEGG path-
ways. We extracted 14 potential transcription factors with
binding sites enriched consistently in each of the differen-
tial gene lists from all 6 datasets (see Additional file 13).
Among these transcription factors, AP-2 [33], SP1 [34],
and NF-kB [35] are either well known or implicated by
many studies to be associated with cancer progression.
Interestingly, only SP1 was also enriched within the 52-
gene common gene list derived from gene-level method
(data not shown). We then extracted 19 miRNAs with
their predicted targets enriched within the differential
gene lists from at least 4 of the 6 total datasets (see Addi-
tional file 14). Among these miRNAs, there are quite a few
that have been previously reported to be aberrantly
expressed in cancer or related to carcinogenesis, and have
been proposed to function as a novel class of oncogenes
or tumor suppressor genes [36-38]. Interestingly, some of
them were also enriched within the 52-gene common
gene list derived from gene-level method, although many
of them were missed from the enrichment result of 52-
gene common gene list (data not shown). Even for KEGG
pathways [4], we extracted 6 KEGG pathways enriched
within the differential gene lists from at least 3 out of the
total 6 datasets (see Additional file 15). Many of these
pathways such as integrin-mediated cell adhesion [39],
MAPK signaling pathway [40], TGF-beta signaling path-
way [41], and Wnt signaling pathway [42] have been
implicated in tumor progression and carcinogenesis.
However, none of these significant KEGG pathways were
enriched within the 52-gene common gene list derived
from gene-level method (data not shown).
These observations suggested that PPEP can not only
identify additional terms or wider biological themes that
may be missed by conventional gene-level based meth-
ods, but also may provide a way to cross-validate the
results derived from the gene-level based methods since it
should also include any such terms.
Seeking unique biological themes specific for tissue types
PPEP can not only help identify common biological
themes among different datasets or studies as described in
the above case study, but also can help uncover unique-
ness of a subset that is distinct from the rest of a dataset or
study. Here, we describe a case study that looks for tissue-
specific biological processes from the well known public
microarray dataset derived from 79 human tissues from
the Genomic Institute of the Novartis Research Founda-
tion (GNF) described previously [43].
We first preprocessed the data by z-score transformation
of the data and then sorted the genes into individual gene
lists as highly expressed genes for each corresponding
sample with the criteria that the z-score was no less than
1. Finally, we subjected these gene lists to the PPEP. The
goal of this analysis is to look for those biological proc-
esses that are uniquely but consistently enriched in highly
expressed genes within certain types of tissues. We chose
to examine those biological processes that are shared
amongst in the testis-related tissues but distinct from the
rest of the tissues in the dataset. We chose the subset, since
there are only 5 testis-related tissues (testis germ cells, tes-
tis interstitial, testis leydig cell, testis seminiferous tubule,
and testis) in the dataset and testis-related biological proc-
esses are relatively unique and specific compared to other
tissues. The analysis result should be easily interpreted
based on their biological expectations.
We set up the pathway pattern extraction template exactly
as illustrated in Figure 3 for annotations of GO biological
processes, which allowed us to find the GO terms that are
enriched in at least 4 of the 5 testis-related tissues but not
enriched in at least 72 of 74 other tissues. We used slightly
relaxed criteria for pathway pattern extraction in this case
to avoid the possible situation where one sample may
have some experimental noise, such as contamination,
causing some relevant terms to be missed in our extracted
patterned term lists as a result of the errors in one (in
Inclusion samples: testis-related tissues) or two (in Exclu-
sion samples or other tissues) samples. Another reason for
the relaxed criteria is the fact that these 5 related tissues are
not exactly the same tissues. Thus, our relaxed criteria may
help overcome the diversity among these testis-related tis-
sues but differentiate them as a group from other types of
tissues. The pathway pattern extraction generated a list of
16 terms, which were visualized in a heatmap using the
enrichment scores of each term for each sample (Figure 4,
see Additional file 16 for the real data). Many of these 16
GO terms appeared to be quite specific to testis-related
functions such as development of primary male sexual
characteristics, fusion of sperm to egg plasma membrane,
male gamete generation, male sex differentiation, sperma-
togenesis, which obviously are exactly what were expected
from the analysis. Some non-testis tissue samples also hadPage 10 of 17
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ple or redundant functions of some genes that may work
in other tissues or resulting from possible accidental
enrichment due to the relatively relaxed selection criteria
for genes (e.g., z-score approach) (Figure 4). Furthermore,
most of these samples were only enriched in one or two
terms except for Ciliary_Ganglion, which are enriched in
5 testis-related functional terms (see Additional file 16).
However, as described in a separate manuscript, our
newly developed method SLEPR may help rank these
terms to position the most relevant terms at the top of the
ranked list [22]. We feel that combining SLEPR and PPEP
within the same application gives biologists access to a
much richer breadth of information to use for exploratory
hypothesis testing.
To compare the gene-level analysis with the PPEP
method, we also obtained the common genes from the
highly expressed gene lists of the 5 testis-related tissues
and subjected them to enrichment analysis on GOBP
terms. We retrieved the top 16 enriched GO terms and
compared them with those 16 GO terms that were identi-
fied using PPEP. Interestingly, many of these top ranked
16 terms derived from common gene list-based approach
in fact were also widely enriched in many non-testis tis-
sues (data not shown), which is in contrast to the behav-
ior of the 16 terms derived from the PPEP. This
observation indicated that PPEP method showed a much
more specific enrichment pattern in testis-related tissues
than the common gene list-based approach. Similar to the
case study with prostate cancer dataset described earlier,
this observation indicates that the gene-level method
appeared to have more difficulty to uncover the unique
biological processes specific for testis-related tissues at the
pathway-level compared to the PPEP method.
To explore what genes are associated with the extracted
testis-specific GO terms, we used the interface shown in
Figure 5 to retrieve the genes for some selected terms in a
format of pairwise relations with the selected GO terms
(see Additional file 2). We can then display the gene-term
relationships in the context of GTANs shown in Figure 6.
Although many associated genes are consistently
expressed in all of the 5 testis-related tissues at a relatively
higher level, there are other genes that are expressed only
in some testis-related tissues (Figure 6).
We also used our PPEP to seek common and unique bio-
logical themes in two-class comparison in another case
study (See Additional file 17 (Additional file 18 and 19)),
which also showed great flexibility and capacity of the
PPEP in such circumstances.
Discussion and Conclusion
Many software tools begin with a gene list, either as differ-
ential genes, or genes with certain biological features or
defined properties, and subject the list to enrichment
analyses (typically overrepresentation analysis (ORA)
[12,13] or GSEA [15,16]). Such analysis usually focuses
on uncovering embedded biological implications in one
gene list or a single data set.
Our high-throughput PPEP is designed to extend this
analysis scheme into a comparative analysis scheme at the
pathway-level for multiple gene lists or multiple HTP
datasets. It is based on the assertion that it has the poten-
tial to integrate data from different, but related studies or
even from different platforms. The advantage of the
method was illustrated by the case study that used 6 pros-
tate cancer datasets from the Oncomine database
described in the result section. Recently, a meta-analysis
method has made great progress trying to integrate data
from different platforms by means of a summary statis-
tics-based method in combination with FDR analysis and
cross-validation [26,44,45]. However, it is still a gene-
level based approach that primarily looks at the consist-
ency of gene behavior across datasets. In contrast, our
high-throughput PPEP is designed to compare genes of
defined gene lists at the pathway-level to determine the
enrichment levels of defined pathways or gene sets. The
idea is to integrate data at the pathway-level for multiple
gene lists or multiple HTP datasets without regard to the
types of the platforms, technologies, and statistical meth-
ods that were applied to generate these datasets or gene
lists. Thus, our results indicate that common or unique
biological themes can effectively be captured at the path-
way-level by means of conducting pattern analysis of the
enrichment levels of functional terms, pathways, or gene
sets across the datasets or gene lists. The genes associated
with these patterned pathways or terms can then be
retrieved, and the data behavior, as well as relationships
with the terms, can be analyzed in the context of GTANs
within the WPS environment [4]. The WPS environment
allows for visualization of data behavior of multiple gene
lists together [4].
As shown in the first case study in the Results section, our
analysis scheme with PPEP effectively uncovers many
common pathway-level signatures from the 6 prostate
cancer datasets. From the analysis done within each indi-
vidual gene list or dataset, some of these common path-
way-level signatures may not be seen as significant, since
they were not ranked at the very top in the enrichment
results of each individual gene list of these independent
studies. However, the consistencies and patterns of path-
way-level enrichment that PPEP relies on adds weight to
these terms and promotes their significance so that they
become significant underlying biological themes acrossPage 11 of 17
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differential genes of these independent studies based on
gene-level consistency as the sole-source for enrichment
analysis, the derived pathway-level signatures may not be
able to get significant enrichment scores. This observation
illustrates the advantage of PPEP compared to conven-
tional gene-level based enrichment methods in rationale.
Our other case studies described in the Results section fur-
ther substantiated the increased ability of PPEP to identify
meaningful biological terms associated with input sets of
gene lists derived from different sources, or with different
technologies.
In comparison with many other gene-set based software
tools, our PPEP has many unique features not found in a
single application (Table 1). Some of the features such as
pathway pattern extraction are only found in our pipeline
as far as we have been able to determine. In a typical ORA
method [46] and FCS method [47], the ranking of the
"significant" over-represented terms can be misleading
due to the fact that the real biologically relevant terms
may not be necessarily ranked at the very top. This results
from the fact that the ranking is purely based on the p-val-
ues or enrichment scores, which in some cases may largely
be influenced by the numbers of genes annotated in the
terms or the size of the gene list. Our pathway-level com-
parative analysis method looks at the patterns of enrich-
ment status (whether enriched or not) that persistently
exist across the gene lists. By design, it ignores the enrich-
ment magnitude (or enrichment levels), which is more
susceptible to the changes in the numbers of genes anno-
tated in the terms or the size of the gene list, as long as the
Table 1: Comparison of major features of PPEP in WPS with other related tools
WPS PPEP Babelomics High-throughput GOminer EASE/DAVID GSEA
Number of gene lists to be analyzed at 
the same time for comparison
Multiple lists 1–2 lists Multiple lists one list a time NA
Batch computation for multiple gene 
lists
Yes No Yes No No
Merging Batch Results for a matrix of 
data











Pattern extraction at pathway 
enrichment level
Yes No No No No
Provide matrix of data for clustering 
analysis at pathway level
*ES, ListHits, or FDRs No Only FDRs No No
Retrieve associated genes from 
selected terms
Yes No No No No
Network and data visualization of the 
associated genes and terms (GTANs)
Yes No No No No
Gene list sorting utility Yes No No No No
Data manipulation utility Yes No No No No
SLEPR pathway ranking method [22] Yes No No No No
Group testing methods using gene sets ORA ORA ORA ORA FCS
The Pathway Pattern Extraction Pipeline (PPEP) in WPS has many unique features not found in a single similar application. Five related tools (first 
row of the table) were selected for comparison of major features (first column of the table) with PPEP in WPS. The other 4 tools for comparison 
include: Babelomics (Fatigo) [13]; HTP GoMiner [14]; EASE/DAVID [12,46]; GSEA [15,16].
ORA: Over-representation analysis [21]; FCS: functional class scoring [47]; *ES: Enrichment score.Page 12 of 17
(page number not for citation purposes)
BMC Bioinformatics 2009, 10:200 http://www.biomedcentral.com/1471-2105/10/200terms are enriched at significant level (e.g., p < 0.05 and
ListHits >= 2). In other words, our method pays more
attention to the terms that are consistently enriched across
gene lists compared to which terms are mostly enriched in
individual lists usually reported by individual ORA analy-
sis (see Additional file 1 for more technical details of
PPEP).
We also have evidence that our pathway pattern extraction
method is more effective than the PTM-based (Pavlidis
template matching) clustering method (TM4) [23] in
uncovering patterned pathways or terms when measured
by completeness and intuitiveness of resulting terms. Our
pathway pattern extraction method can easily extract the
complete set of patterned terms, whereas the PTM cluster-
ing method may have to test different p-values before
reaching the best match (see Additional file 20). The main
distinction is that the PTM clustering method is based on
the actual values (how closely the values (i.e. ESs or
enrichment scores) are related to each other) and our
pathway pattern extraction is based on the categorized
calls (enriched or not). In other words, our pathway pat-
tern extraction looks for the patterned enrichment status
(enriched or not) rather than the enrichment magnitude
(how significant it is enriched in terms of the p-values or
enrichment scores). Thus, our method may be more effec-
tive in picking up the patterns and more realistic in con-
sidering the enrichment status rather than the enrichment
scores that may be influenced by many factors.
As demonstrated by our case studies using our PPEP,
many commonly shared biological themes can be easily
captured from multiple gene lists derived from related,
but different studies. The same themes are not obvious
when simply looking at the common genes shared by
these lists at both the gene and pathway-level. In addition,
the unique biological themes, which are specific to one or
more gene lists, but not to others, can be uncovered as list-
specific biological processes at the pathway-level. For
example, for closely related tissues such as the 5 testis-
related tissues (testis germ cells, testis interstitial, testis
leydig cell, testis seminiferous tubule, and testis) in the
case study using the GNF dataset [43], since they are, in
fact, different tissues, it may be more appropriate to expect
higher similarity in biological processes at pathway-level
than at gene-level. Thus, the difference between testis-
related tissues would be less profound at the pathway-
level than that at gene-level. This notion has been
extended to a novel approach that can be also applied to
common class comparison analysis in our newly devel-
oped SLEPR method described in a separate manuscript
[22], which considers sample-level variations of individ-
ual genes.
Many efforts have been made to look for biological
themes using networks of associated genes. These are
largely based on curated gene-gene relationships from the
literature [9,10]. The pure pathway/network approach
often encounters issues of complexity of networks that are
generated from a relatively large list of statistically signifi-
cant genes. Without considering the major trends for bio-
logical themes embedded in the gene list, it would be
rather hard to derive biological insights from these net-
works. In a more complicated situation where there are
multiple gene lists from different studies and one wishes
to compare the embedded biological themes from them,
directly applying these gene lists into the networks would
be rather difficult to sort out the underlying biological
themes. This stems from a lack of an accepted and robust
method for comparing the derived network of each list.
Until such a method can be tested, it would be a better
choice to use our pathway pattern extraction approach
looking for common and unique biological themes first,
before subjecting the associated genes of the selected
terms to network analysis. This would not only simplify
the size of the gene list used for the network analysis, but
also may use more relevant genes to create a more mean-
ingful network that may provide better insights into the
underlying biological themes.
Before describing PPEP in this manuscript, it has been
widely used for analysis of many of our collaborators' data
including microarray datasets, mass spectrometry data,
data from a genetic screening for functional impact study
of virus insertion sites in the genome, lists of genes with
specific features embedded in their sequences [[48-54],
many unpublished studies]. It has successfully uncovered
many underlying biological themes that gene-level meth-
ods might have missed or failed to reveal. The analysis
results have been included in many published studies
with our collaborators using different biological systems
including breast cancer [48], prostate cancer [49,50], yeast
genetics [51], malaria drug-resistance studies [52], color-
ectal cancer [53] and Parkinson disease [54] where it
helped uncover underlying biological themes. Given the
insights derived from the analysis using the PPEP, we
believe that the new analysis scheme provided by this
pipeline will be very helpful in compensating for some of
the limitations of gene-level based analysis, and provide a
valuable perspective of data sets from a pathway point of
view. With a better coverage of associated genes for
desired pathways and biological processes, our method
yields a better chance to envision a more complete picture
of biological themes (e.g., behavior of genes at the path-
way-level or as a functional group for each individual
samples) despite individual variations in gene lists or
from datasets derived from independent studies with dif-
ferent rationales, technology platforms, and/or sampling
populations.Page 13 of 17
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Project name: Pathway pattern extraction pipeline (PPEP)
in WPS
Project home page: WPS with PPEP and corresponding
databases (WPS version 2) can be downloaded from WPS
homepage [55]. The demo movies for PPEP can be
accessed through the demo page of the WPS homepage.
Operating system: Microsoft Window 2000 or XP
Programming language: Microsoft Visual Basic 6
Other requirements: Built on the platform of WPS [55].
License: Free to academics; distributed through license
agreement
Any restrictions to use by non-academics: commercial
license needed
List of abbreviations used
WPS: WholePathwayScope; ES: Enrichment Score; GTAN:
Gene-Term Association Network; HTTP: High Through-
put; KEGG: Kyoto Encyclopedia of Genes and Genomes;
GO: Gene Ontology; GOBP: Gene Ontology: Biological
Processes category; PPEP: Pathway Pattern Extraction
Pipeline; ORA: Over-representation analysis; FCS: func-
tional class scoring; GSEA: Gene Set Enrichment Analysis.
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More details of PPEP. More technical details, features, and implementa-
tions of PPEP.




The gene-term pairwise relation table. The gene-term pairwise relation 
table that was retrieved using an interface as illustrated in Figure 5. Such 
a file content can be used in WPS to create the GTAN (gene-term associ-
ation network).




The interface of data manipulation utilities. The image file showing the 
interface of data manipulation utilities in WPS.




The interface for data scoring and lists sorting. The image file showing 
the interface for data scoring and lists sorting for SLEPR method [22] 
available in PPEP.




Common differential genes among all datasets. list of 52 genes that 
were obtained as common differential genes among all of the 6 datasets 
using gene pattern extraction feature in WPS in the prostate cancer case 
study.




common GSEA annotation terms among all datasets. list of 331 terms 
that were obtained as common GSEA annotation terms among all of the 
6 datasets using pathway pattern extraction feature in PPEP of WPS in 
the prostate cancer case study.




Enrichment result of GSEA annotations for the 52 common differen-
tial genes. The full enrichment result of GSEA annotations for the 52 
genes that were obtained as common differential genes among all of the 6 
datasets in prostate cancer case study.




Pathway-level enrichment patterns of commonly enriched GSEA 
terms. The heatmap of pathway-level enrichment patterns of the 33 com-
monly enriched GSEA terms among the differential genes of 6 datasets in 
prostate cancer case study that are directly involved in cancer-related proc-
esses.




Comparison of results of PPEP and gene-level method for cancer-
related terms. The merged table in between the 33 cancer-related terms 
enriched commonly in 6 datasets of prostate cancer case study and the 
terms that have at least one gene out of the 52-gene common gene list, 
which shows that only 7 of the 33 terms are enriched in 52-gene list.
Click here for file
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